Emerging health care technologies in diabetes: is it the way forward?

Chawla R. Telemedicine in Covid-19 pandemic. ERWEJ. 2022;2(1):01–02. https://doi.org/10.54136/ERWEJ-0201-10020. Verma R, Bhardwaj S, Lathia T, Kalra S. Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 days. IJDDC. 2023;43(3). Chawla R, Jaggi S, Gupta A, Bantwal G, Patil S. Clinical utility of a digital therapeutic intervention in Indian patients with type 2 diabetes mellitus: a 12-week, prospective, single-arm, intervention study. JMIR. 2022. Zhang J, Liu X, Wei L, Zeng Q, Lin K. Telemedicine with advanced communication technology in management of type 2 diabetes mellitus: a network meta-analysis. IJDDC. 2023;43(3). Chawla R, Chawla S, Jaggi S, Chawla A, Kumar R. Diabetes care during COVID-19 pandemic using a telehealth approach: abstract #1042697. Endocr Pract. 2021;27:S24-S71. Bassi A, Arfin S, John O, Praveen D, Arora V, Kalra OP, Madhu SV, Jha V. Innovative mobile- health led participatory approach to comprehensive screening and treatment of diabetes (IMPACT diabetes): rationale, design and baseline characteristics. IJDDC. 2023;43(3).